bkuang@cooley.com
Barry Kuang focuses his practice on a wide range of general corporate matters, mergers and acquisitions, venture capital financings, cross border transactions and late-stage transactions.
Download full bio
CinCor Pharma – $212 Million IPO
SmartAsset's Valuation Climbs to $1 Billion+ With Series D Round
Emerging Companies
Mergers & Acquisitions
Venture Capital
Private Equity
Capital Markets
Northeastern University School of Law JD, 2019
University of UtahBS, Economics and Political Science2013
Massachusetts
SmartAsset's Valuation Climbs to $1 Billion+ With Series D Round June 30, 2021
+1 617 937 2476
Locations